This article, written with co-authors Bruce H. Kobayashi, Joshua D. Wright, and Douglas H. Ginsburg, examines the economics of litigation and settlement of patent disputes arising from Paragraph IV Abbreviated New Drug Application (ANDA) filings under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act) within the framework set out in Actavis.
Four US Competition experts recognized as Global Elite Thought Leaders by Who's Who Legal
CRA is proud to announce that Andrew Dick, Elizabeth Bailey, Michelle Burtis, and Steven Salop have been recognized as Global Elite Thought Leaders in...